Letrozole and Cellulitis - a phase IV clinical study of FDA data
Summary:
Cellulitis is found among people who take Letrozole, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Letrozole and have Cellulitis. It is created by eHealthMe based on reports of 39,784 people who have side effects when taking Letrozole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
39,784 people reported to have side effects when taking Letrozole.
Among them, 412 people (1.04%) have Cellulitis.
What is Letrozole?
Letrozole has active ingredients of letrozole. It is often used in breast cancer. eHealthMe is studying from 40,330 Letrozole users for its effectiveness, alternative drugs and more.
What is Cellulitis?
Cellulitis (infection under the skin) is found to be associated with 2,984 drugs and 2,239 conditions by eHealthMe.
Number of Letrozole and Cellulitis reports submitted per year:
Time on Letrozole when people have Cellulitis *:
Gender of people who have Cellulitis when taking Letrozole*:
Age of people who have Cellulitis when taking Letrozole *:
Common drugs people take besides Letrozole *:
Common side effects people have besides Cellulitis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Letrozole and have Cellulitis?
Check whether Cellulitis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Related studies
How severe was Cellulitis and when was it recovered:
Expand to all the drugs that have ingredients of letrozole:
- Cellulitis and drugs with ingredients of letrozole (778 reports)
Alternative drugs to, pros and cons of Letrozole:
- Letrozole (40,330 reports)
Common Letrozole side effects:
- Fatigue (feeling of tiredness): 5,878 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 3,799 reports
- Diarrhea: 3,274 reports
- Hair loss: 3,153 reports
- Joint pain: 2,489 reports
Browse all side effects of Letrozole:
a b c d e f g h i j k l m n o p q r s t u v w x y zCellulitis treatments and more:
- Cellulitis (66,241 reports)
COVID vaccines that are related to Cellulitis:
- Cellulitis in Moderna COVID Vaccine
- Cellulitis in Pfizer BioNTech Covid Vaccine
- Cellulitis in Johnson and Johnson Covid Vaccine
Common drugs associated with Cellulitis:
- Prednisone: 5,344 reports
- Methotrexate: 4,308 reports
- Aspirin: 3,510 reports
- Humira: 3,005 reports
- Enbrel: 2,968 reports
- Lasix: 2,889 reports
- Furosemide: 2,688 reports
- Fosamax: 2,469 reports
- Metformin: 2,219 reports
- Omeprazole: 2,198 reports
All the drugs that are associated with Cellulitis:
- Cellulitis (2,984 drugs)
Common conditions associated with Cellulitis:
- Rheumatoid arthritis: 6,424 reports
- Multiple sclerosis: 3,251 reports
- Psoriasis: 2,980 reports
- High blood pressure: 2,973 reports
- Osteoporosis: 2,533 reports
- Pain: 2,287 reports
- Multiple myeloma: 2,176 reports
All the conditions that are associated with Cellulitis:
- Cellulitis (2,239 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on letrozole (the active ingredients of Letrozole) and Letrozole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Multiple Myeloma and drugs of ingredients of trametinib dimethyl sulfoxide - 8 seconds ago
- Gastritis and Urticaria - 10 seconds ago
- Cyclobenzaprine Hydrochloride and Anorectal Abscess - 10 seconds ago
- Estarylla and Reglan drug interaction - 12 seconds ago
- Zoladex and Tooth Fracture - 13 seconds ago
- Montelukast Sodium and Procedural Pain - 17 seconds ago
- Oncovin and Salivary Gland Infections - 26 seconds ago
- Benlysta and Hypoaesthesia Eye - 28 seconds ago
- Norfloxacin and Altered State Of Consciousness - 29 seconds ago
- Rosiglitazone Maleate and Skin Warm - 38 seconds ago